Predictions
iRhythm Technologies Inc
Start price
Target price
Perf. (%)
€137.00
29.03.22
29.03.22
-
29.03.23
29.03.23
-16.79%
29.03.23
29.03.23
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.05
03.01.23
03.01.23
-
03.01.24
03.01.24
-73.34%
28.03.23
28.03.23
Could be worthwhile Investment >10% per year
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€64.50
22.03.22
22.03.22
-
22.03.23
22.03.23
-43.57%
23.03.23
23.03.23
Voyager Therapeutics Inc
Start price
Target price
Perf. (%)
€7.65
21.03.22
21.03.22
€11.00
21.03.23
21.03.23
-7.01%
22.03.23
22.03.23
Could be worthwhile Investment >10% per year
Higher risks for its business
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.04
08.03.23
08.03.23
€34.00
08.03.24
08.03.24
-22.54%
21.03.23
21.03.23
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€7.14
05.03.23
05.03.23
-
05.03.24
05.03.24
-22.15%
18.03.23
18.03.23
Probably not worthwhile Investment
Very low/no dividend yield expected
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.43
06.03.23
06.03.23
-
06.03.24
06.03.24
-23.34%
17.03.23
17.03.23
Risky Investment
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€4.44
06.03.23
06.03.23
-
06.03.24
06.03.24
-57.46%
17.03.23
17.03.23
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.29
06.03.23
06.03.23
-
06.03.24
06.03.24
-13.18%
17.03.23
17.03.23
Risky Investment
Novavax Inc.
Start price
Target price
Perf. (%)
€6.62
01.03.23
01.03.23
-
01.03.24
01.03.24
-15.51%
17.03.23
17.03.23
Could be very worthwhile Investment >20% year
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€21.29
16.03.22
16.03.22
€56.00
16.03.23
16.03.23
149.27%
17.03.23
17.03.23
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Innate Pharma
Start price
Target price
Perf. (%)
€2.51
07.03.22
07.03.22
-
07.03.23
07.03.23
21.39%
08.03.23
08.03.23
Probably not worthwhile Investment
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€4.76
11.12.22
11.12.22
-
11.12.23
11.12.23
-6.82%
06.03.23
06.03.23
Could be worthwhile Investment >10% per year
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€14.57
01.03.22
01.03.22
-
01.03.23
01.03.23
-43.77%
02.03.23
02.03.23
Aclaris Therapeutics Inc
Start price
Target price
Perf. (%)
€11.54
21.02.22
21.02.22
€15.00
21.02.23
21.02.23
2.90%
22.02.23
22.02.23
Could be worthwhile Investment >10% per year
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.04
07.02.23
07.02.23
€1.00
07.02.24
07.02.24
-7.35%
18.02.23
18.02.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.44
22.01.23
22.01.23
-
22.01.24
22.01.24
-30.29%
16.02.23
16.02.23
Inovio Pharma
Start price
Target price
Perf. (%)
€1.74
03.10.22
03.10.22
€2.35
03.10.23
03.10.23
-15.49%
13.02.23
13.02.23
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Innate Pharma
Start price
Target price
Perf. (%)
€3.24
10.02.22
10.02.22
€3.80
10.02.23
10.02.23
-4.81%
11.02.23
11.02.23
Could be worthwhile Investment >10% per year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.44
23.01.23
23.01.23
€33.00
23.01.24
23.01.24
-0.24%
06.02.23
06.02.23
Could be very worthwhile Investment >20% year
Sientra Inc.
Start price
Target price
Perf. (%)
€1.84
02.02.23
02.02.23
€3.60
02.02.24
02.02.24
-4.62%
06.02.23
06.02.23
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€15.03
05.02.22
05.02.22
€20.00
05.02.23
05.02.23
-57.41%
06.02.23
06.02.23
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.75
26.12.22
26.12.22
-
26.12.23
26.12.23
48.74%
05.02.23
05.02.23
Risky Investment
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€1.11
01.02.23
01.02.23
-
01.02.24
01.02.24
-0.36%
05.02.23
05.02.23
Risky Investment
Novavax Inc.
Start price
Target price
Perf. (%)
€87.29
01.02.22
01.02.22
-
01.02.23
01.02.23
-88.23%
02.02.23
02.02.23
Could be worthwhile Investment >10% per year
Fair valuation
Revenue growth >5% per year expected
Standard Investments for future growth